Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(543)
•••
Post by mdjbrownon Feb 07, 2024 9:44am
145 Views
Post# 35867178

Looking forward to Labs naming their Brazilian Partner

Looking forward to Labs naming their Brazilian PartnerYou dont go through the rigorous GMP Certification international inspection process for a casual overseas customer relationship.  They already had that with XLR8. 

From Anvisa:

“Please note that it is not possible for foreign companies to make administrative arrangements for issuing of certificates directly with Anvisa. Foreign companies shall have partner companies legally constituted in Brazil that will be legally responsible for the products imported to and distributed in the Brazilian territory.” 

https://www.gov.br/anvisa/pt-br/english/regulation-of-companies


With Verdemed recently reporting they would be tapping into the generic Epidiolex, Dronibonol, markets in Brazil, is Medipharm now directly in line to compete with them with GMP approved imports?

 https://www.benzinga.com/markets/cannabis/23/08/34012145/epidiolex-counterpart-debuts-in-brazils-cannabis-market-as-its-maker-eyes-tsx-ipo
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities